Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- As Pfizer/Mylan’s Generics Merger Closed, 4 Viatris Group Firms to Operate Together in Japan
November 18, 2020
- Japan Pharma Market Shrivels 5.1% on COVID-19 Crisis in July-Sept.: IQVIA
November 18, 2020
- Eisai’s Fycompa Gets Pediatric Nod in Europe
November 17, 2020
- Janssen Resumes Japan PI for COVID-19 Vaccine after Temporary Pause
November 17, 2020
- Shionogi Forms Consortium with Univ. of Cambridge, AZ for Digitalized Chemical Synthesis
November 17, 2020
- Medicago, GSK Commence PII of Adjuvanted COVID-19 Vaccine, Progressing into PIII during December
November 17, 2020
- Otsuka’s Pharma Sales Grow 6.3% in January-September on Global Brands
November 16, 2020
- Some Hospitals Shun New Nichi-Iko Generics after Massive Recalls, President Reveals
November 13, 2020
- Generic Makers Seeking to Invalidate Feburic Patent, Can They Get Full Indications?
November 13, 2020
- Fuji Pharma, M3 Join Hands on Dysmenorrhea Med in Japan
November 13, 2020
- Voluntary Recalls Launched for Pfizer/MSD’s Antidepressant Trazodone
November 13, 2020
- Sagent Launches US PII to Test Camostat Mesilate for COVID-19
November 13, 2020
- Humira’s Pediatric Dosage Filed for Ulcerative Colitis in Japan: AbbVie
November 13, 2020
- Osaka Univ. Spin-Off Boots Up to Develop First Treatment for Skeletal Muscle Damage, Atrophy
November 13, 2020
- PeptiDream, 4 Other Firms Establish JV to Develop COVID-19 Therapeutics
November 13, 2020
- Ex-Daiichi Sankyo Chairman Kiyoshi Morita Dies at 81
November 13, 2020
- Fujifilm Grants Rights to Patent on iPS Cell Generation to Lonza
November 13, 2020
- Taiho Obtains Japan Rights for US Firm’s Loculated Pleural Effusion Med
November 13, 2020
- AstraZeneca Launches Healthcare Innovation Hub in Japan
November 12, 2020
- Nippon Kayaku’s Biosimilar Sales to Hit 10 Billion Yen Mark in Full-Year, Trastuzumab Upbeat
November 12, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…